Welcome to our dedicated page for Kontrol Technologies news (Ticker: KNRLF), a resource for investors and traders seeking the latest updates and insights on Kontrol Technologies stock.
Kontrol Technologies Corp (KNRLF) delivers industrial automation solutions through integrated control systems and IoT technologies. This dedicated news page aggregates official announcements, financial updates, and strategic developments for investors and industry analysts. Access verified information on KNRLF's innovations in smart infrastructure and process optimization.
Key updates include earnings reports, product releases, partnership agreements, and industry recognitions. The curated content provides clarity on the company's growth trajectory within the automation sector while maintaining focus on technological advancements. Regular updates ensure stakeholders stay informed about operational milestones and market positioning.
Bookmark this resource for centralized access to Kontrol Technologies' latest news. Check back frequently for real-time updates directly from corporate communications and trusted financial sources.
Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) announced a collaboration with Foyer Richelieu Welland, a long-term care facility in Ontario, to implement its Kontrol BioCloud technology. This real-time viral detection system aims to monitor airborne pathogens, including COVID-19. CEO Paul Ghezzi emphasized the importance of BioCloud in creating safer environments, especially in light of ongoing COVID-19 protocols. The partnership focuses on ensuring a secure space for residents through effective real-time monitoring.
Kontrol Technologies Corp. (CSE:KNR, OTCQB:KNRLF) is set to showcase real-time demonstrations of its BioCloud units across various customer applications, pending approvals. The company's CEO, Paul Ghezzi, emphasized the importance of sharing operational data when permissible. Additionally, Kontrol has reduced the number of circuit boards in BioCloud from 11 to 5, enhancing production efficiency and potentially lowering costs. With 11 distributors and ongoing negotiations for USA and Middle East agreements, Kontrol is adapting its distribution model to optimize market presence.
Kontrol Technologies Corp. (CSE:KNR, OTCQB:KNRLF) has established a scientific advisory board to accelerate the development of its BioCloud technology for real-time viral detection. CEO Paul Ghezzi emphasizes the necessity of advanced detection technology alongside vaccines for economic recovery. The advisory board comprises prominent experts, including Dr. Caroline Duchaine and Dr. David Heinrichs, who will guide the innovation of BioCloud applications. This initiative positions Kontrol as a leader in the emerging field of viral detection technology.
Kontrol Technologies Corp. has received approval from the Canadian Securities Exchange to change its name to Kontrol Technologies Corp., effective February 12, 2021. The company's share ticker symbols will remain unchanged: CSE: KNR, OTCQB: KNRLF, and FSE: 1K8. No action is required from shareholders due to this name change, and existing share certificates will remain valid. The company specializes in smart buildings through IoT, Cloud, and SaaS technologies aimed at improving energy management and air quality.
Kontrol Technologies Corp. (CSE:KNR / OTCQB:KNRLF) has engaged Digital Offering, LLC as its financial advisor to explore U.S. Capital Markets and aim for a potential NASDAQ listing. CEO Paul Ghezzi emphasized the importance of increasing visibility in the U.S. market. Digital Offering will receive an initial fee of US $25,000 and a success fee of US $175,000 upon a successful listing, along with 400,000 consultant warrants. Kontrol is focused on enhancing its institutional shareholder base and long-term value.
Kontrol Technologies Corp. has announced a $2 million investment from the Ontario government through the Ontario Together Fund to accelerate the production of its innovative COVID-19 detection technology, BioCloud. This funding will enable CEM Specialties Inc., a subsidiary of Kontrol, to increase production capacity to 20,000 units per month, creating up to 250 direct and 750 indirect jobs. BioCloud will provide real-time monitoring of SARS-CoV-2 in the air and is designed for various public spaces. The investment is contingent on achieving specific production milestones by March 30, 2021.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) is set to ship its BioCloud unit to the UAE for a three-week field demonstration starting December 13, 2020. CEO Paul Ghezzi noted significant regional interest in the viral detection technology. The BioCloud unit will now support modbus and bacnet protocols for integration with HVAC systems, enhancing its applicability in smart building environments. This upgrade applies to all future units as well. BioCloud operates as a real-time air quality analyzer, although it does not claim to eliminate or cure COVID-19.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) has signed an exclusive Distribution Agreement with United Safety and Survivability Corporation to distribute its BioCloud technology in North America, Australia, and New Zealand. The agreement spans a 12-month exclusivity period, with a mutual six-month renewal option, covering various transportation sectors including buses and ambulances. The arrangement targets production of 5,000 units annually. However, pricing details remain undisclosed for competitive reasons. The BioCloud technology aims to enhance air quality and safety in public spaces impacted by COVID-19.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) announced its financial results for the nine months ending September 30, 2020. Despite the impact of COVID-19, Q3 2020 revenue rose by 32% over Q2 2020 to $3.01 million, though down from $3.27 million in Q3 2019. Adjusted EBITDA for Q3 was $848,249 compared to $206,435 in the same quarter last year. Net loss reduced to $193,541 from $692,175. The company's cash position improved to approximately $3.8 million as of the press release date, bolstered by exercises of options and warrants.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) announced the filing of four patent applications for its BioCloud Technology, aimed at detecting airborne pathogens. Three applications were submitted to the U.S. Patent and Trademark Office and one to the Canadian Intellectual Property Office. The BioCloud technology utilizes continuous air quality monitoring and a detection chamber to enhance air safety in shared spaces. CEO Paul Ghezzi emphasized the company's commitment to innovation. However, the technology is not a medical device and does not claim to eliminate COVID-19.
